Nerve growth factor and transforming growth factor-β in progressive renal disease

Biomedical Reviews

Volumn 16, Issue , 2005, Pages 23-34

  Bonofiglio, Renzo ^a   Caroleo, Maria Cristina ^b   Antonucci, Maria Teresa ^b   Papalia, Teresa ^a   Aloe, Luigi ^c  

^a ANNUNZIATA HOSPITAL   (Italy)

^b UNIVERSITY OF CALABRIA   (Italy)

^c EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Fibrosis; Glomerulonephritis; Hemodialysis; Inflammation; Kidney; NGF receptor

Indexed keywords

NERVE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

DISEASE COURSE; HEMODIALYSIS; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FIBROSIS; MYOFIBROBLAST; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REVIEW; WESTERN BLOTTING;

ANIMALIA;

EID: 33845952947     PISSN: 1310392X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Torrey TW. Morphogenesis of the vertebrate kidney. In: De Haan RL, Ursprung H, editors. Organogenesis. University Chicago Press 1965; 580-588.
2. Barajas L, Salido EC, Laborde NP, Fisher DA. Nerve growth factor immunoreactivity in mouse kidney: an immuno-electron microscopic study. J Neurosci Res 1987; 18: 418-424.
3. Durbeej M, Soderstrom S, Ebendal T, Birchmeier C, Ekblom P. Differential expression of neurotrophin receptors during renal development. Development 1993; 119: 977-989.
4. Hammerman MR. Growth factors in renal development. Semin Nephrol 1995; 15: 291-299.
5. Huber LJ, Hempstead B, Donovan MJ. Neurotrophin and neurotrophin receptors in human fetal kidney. Dev Biol 1996; 179: 369-381.
6. Tikkanen I, Uhlenius N, Tikkanen T, Miettinen A, Tornroth T, Fyhrquist F, et al. Increased renal expression of cytokines and growth factors induced by DOCA-NaCl treatment in Heymann nephritis. Nephrol Dial Tranplant 1995; 12: 2192-2198.
7. Di Girolamo P, Arcamone N, Lucini C, Castaldo L, Vega JA, Gargiulo G. The teleost kidney expresses Trk neurotrophin receptor-like proteins. Anat Embryol (Berl) 2000; 201: 429-433.
8. Onodera H, Nagata T, Kanazawa M, Taguma Y, Itoyama Y. Increased plasma GDNF levels in patients with chronic renal diseases. Nephrol Dial Transplant 1999; 14: 1604-1605.
9. Wang W, Koka V, Lan HY. Transforming growth factor-β and Smad signalling in kidney diseases. Nephrology 2005; 10: 48-56.
10. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 4: 1154-1162.
11. Aloe L, Tirassa P, Bracci-Laudiero L. Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives. Curr Pharm Des 2001; 7: 113-123.
12. Charchar FJ, Kapuscinski M, Harrap SB. Persistent reduction in renal nerve growth factor mRNA after perindopril treatment of young spontaneously hypertensive rats. Hypertension 1998; 31: 678-683.
13. Aloe L, Levi-Montalcini R. Enhanced differentiation of sexually dimorphic organs in L-thyroxine treated Tfm mice. Cell Tissue Res 1980; 205: 19-29.
14. Sofroniew MV, Howe CL, Mobley WC. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 2001; 24: 1217-1281.
15. Aloe L, Calzà L, editors. NGF and Related Molecules in Health and Disease. Prog Brain Res 2004; 146. Elsevier, Amsterdam, Netherlands.
16. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456.
17. Brenner BM, Mayer TW, Hosteller TH. Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 1982; 307: 652-659.
18. Anderson S, Meyer TW, Brenner BM. The role of hemodynamic factors in the initiation and progression of renal disease. J Urol 1985; 133: 363-368.
19. Latta H, Maunsbach AB, Madden SC. The centrolobular region of the renal glomerular studied by electron microscopy. J Ultrastruct Mol Struct Res 1960; 4: 455-472.
20. Chaldakov GN, Vankov VN. Morphological aspects of secretion in the arterial smooth muscle cell, with special reference to Golgi complex and microtubular cytoskeleton. Atherosclerosis 1986; 63: 175-192.
21. Cassiman D, Roskams T. Beauty in the eye of the beholder: emerging concepts and pitfalls in the hepatic stellate cell research. J Hepatol 2002; 37: 527-535.
22. Cassiman D, Denef C, Desmet VJ, Roskams T. Human and rat hepatic stellate cells express neurotrophins and neurotrophin receptors. Hepatology 2001; 33: 148-158.
23. Zimmermann A, Gloor B, Kappeler A, Uhl W, Friess H, Buchler MW. Pancreatic stellate cells contribute to regeneration early after acute necrotising pancreatitis in humans. Gut 2002; 51: 574-578.
24. Sedor JR, Carey SW, Emancipator SN. Immune complexes bind to cultured rat glomerular cells to stimulate superoxide release. J Immunol 1987; 138: 3751-3757.
25. Schlondorff D, Goldwasser P, Neuwirth R, Satriano JA, Clay KL. Production of platelet-activating factor in glomerulus and cultured glomerular mesangial cells. Am J Physiol 1986; 250: F1123-F1127.
26. Lovett DH, Rayan JL, Sterzel RB. A thymocyte activating factor from glomerular mesangial cells. J Immunol 1983; 130: 1796-1801.
27. Abboud HE, Popptic E, Di Corletto P. Production of platelet-derived growth factor like protein by rat mesangial cells in culture. J Clin Invest 1987; 80: 675-683.
28. Sraer J, Foidart J, Chansel D, Mahieu P, Konznetzova B, Ardaillou R. Prostaglandin synthesis by mesangial cells and epithelial glomerular cultured cells. FEBS Lett 1979; 104: 420-424.
29. Baud L, Oudient JP, Bens M, Noel L, Peraldi MN, Rondeau E, et al. Production of tumor necrosis factor by rat mesangial cells in response to bacterial lipopolysaccharide. Kidney Int 1989; 35: 1111-1118.
30. Wiggins RC, Njoku N, Sedor JR. Tissue factor production by cultured rat mesangial cells. Stimulation by TNFα and lipopolyssacaride. Kidney Int 1990; 37: 1281-1285.
31. Shultz PJ, Sweeney C, Tayeh M. Activated rat mesangial cells (MC) synthesize nitric oxide (NO) from L-arginine which results in autocrine increases in cGMP. J Am Soc Nephrol 1990; 1: 731 [Abstract].
32. Kagami S, Shimizu M, Kondo S, Kitamura A, Urushihara M, Takamatsu M, et al. Up-regulation of integrin-linked kinase activity in rat mesangioproliferative glomerulonephritis. Life Sci 2006; in press.
33. Gomez-Guerrero C, Hernandez-Vargas P, Lopez-Franco O, Ortiz-Munoz G, Egido J. Mesangial cells and glomerular inflammation: from pathogenesis to novel therapeutic approaches. Curr Drug Targets Inflamm Allergy 2005; 4: 341-351.
34. Border WA. Distinguishing minimal-change disease from mesangial disorder. Kidney Int 1988; 34: 419-434.
35. Risdon RA, Sloper JC, De Wardemer HE. Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular-nephritis. Lancet 1968; 1: 363-366.
36. Hooke DH, Gee DC, Atkins RC. Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987; 31: 964-972.
37. Eddy A. Proteinuria and interstitial injury. Nephrol Dial Transplant 2004; 19: 277-281.
38. Remuzzi G. Nephropathic nature of proteinuria. Curr Opin Nephrol Hypertens 1999; 8: 655-663.
39. Nath K. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 1992; 20: 1-17.
40. Benigni A, Zoja C, Remuzzi G. The renal toxicity of sustained glomerular protein traffic. Lab Invest 1995; 73: 461-468.
41. Zoja C, Morigi M, Figliuzzi M, Bruzzi I, Oldroyd S, Benigni A, et al. Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 1995; 26: 934-941.
42. Wang Y, Chen J, Tay YC, Rangan GK, Harris DCH. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8: 1537-1545.
43. Rovin BH, Doe N, Tan LC. Monocyte chemoattractant protein-1 levels in patients with glomerular disease. Am J Kidney Dis 1996; 27: 640-646.
44. Rangan GK, Wang Y, Tay YC, Harris DC. Inhibition of NFkB activation with antioxidants is correlated with reduced cytokine transcription in PTC. Am J Physiol 1999; 277: F779-F789.
45. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, et al. Protein overload stimulates RANTES production by proximal tubular cells depending on NFkB activation. Kidney Int 1998; 53: 1608-1615.
46. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
47. Wenzel UO, Abboud HE. Chemokines and renal disease. Am J Kidney Dis 1995; 26: 982-994.
48. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, et al. Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993; 43: 354-358.
49. Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, et al. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury. Exp Nephrol 1996; 4: 213-221.
50. Zoja C, Liu XH, Abbate M, Corna D, Schiffrin EL, Renuzzi G, et al. Angiotensin II blockade limits tubular protein overreabsorption and the consequent upregulation of endothelin 1 gene in experimental membranous nephropathy. Exp Nephrol 1998; 6: 121-131.
51. Eddy AA, Giachelli CM. Renal expression of gene that promote interstitial inflammation and fibrosis in rats with protein overload proteinuria. Kidney Int 1995; 47: 1546-1557.
52. Biancone L, David S, Della Pietra V, Montrucchio G, Cambi V, Camusi G. Alternative patway activation of complement by cultured human proximal tubular epithelial cells. Kidney Int 1994; 45: 451-460.
53. Barnes PJ, Karin M. Nuclear factor kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336: 1066-1071.
54. Eddy A. Molecular insights into renal interstitial fibrosis. J Am Soc Nephrol 1996; 7: 2495-2508.
55. Eddy A. Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int (Suppl) 1996; 54: S-49.
56. Strutz F, Okada H, Lo CW, Danoff T, Carone RL, Tomaszewski JE, et al. Identification and characterization of a fibroblast marker: FSP1. J Cell Biol 1995; 130: 393-405.
57. Okada H, Danoff TM, Kalluri R, Neilson EG. Early role of Fsp1 in epithelial-mesenchymal transformation. Am J Physiol 1997; 273: F563-F574.
58. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AM, Mu W, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int 1998; 54: 864-876.
59. Yang J, Liu Y. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am J Pathol 2001; 159: 1465-1475.
60. Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis. J Am Soc Nephrol 2002; 13: 96-107.
61. Li JH, Zhu HJ, Huang XR, Lai KN, Johnson RJ, Lan HY. Smad 7 inhibits fibrotic effect of TGF-β on renal tubular epithelial cells by blocking Smad 2 activation. J Am Soc Nephrol 2002; 13: 1464-1472.
62. Ibarrola N, Kratchmarova I, Nakajima D, Schiemann WP, Moustakas A, Pandey A, et al. Cloning of novel signaling molecule, AMSH-2, that potentiates transforming growth factor-β signaling. BMC Cell Biol 2004; 5: 2.
63. Valcourt U, Kowanetz M, Niimi H, Heldin CH, Moustakas A. TGF-β and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol Biol Cell 2005; 16: 1987-2002.
64. Moustakas A, Heldin CH. Non-Smad TGF-β signals. J Cell Sci 2005; 118: 3573-3584.
65. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiam P, Wakefield L, et al. Hepatic expression of mature transforming growth factor β1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 1995; 92: 2572-2576.
66. Heese K, Beck KF, Behrens MH, Pluss K, Fierlbeck W, Huwiler A, et al. Effects of high glucose on cytokine-induced nerve growth factor (NGF) expression in rat mesangial cells. Biochem Pharmacol 2003; 65: 293-301.
67. Yu G, Fahnestock M. Differential expression of nerve growth factor transcripts in glia and neurons and their regulation by transforming growth factor-β 1. Brain Res Mol Brain Res 2002; 105: 115-125.
68. Jones SE, Kelly DJ, Cox AJ, Zhang Y, Gow RM, Gilbert RE. Mast cell infiltrates and chemokine expression in progressive renal disease. Kidney Int 2003; 64: 906-913.
69. Miyazawa S, Hotta O, Doi N, Natori Y, Nishikawa K, Natori Y. Role of mast cells in the development of renal fibrosis: use of mast cell-deficient rats. Kidney Int 2004; 65: 2228-2237.
70. Micera A, Vigneti E, Pickholtz D, Reich R, Pappo G, Bonini S, et al. Nerve growth factor displays stimulatory effects on human skin and lung fibroblast demonstrating a direct role for this factor in tissue repair. Proc Natl Acad Sci USA 2001; 98: 6162-6167.
71. Alpers CE, Hudkins KL, Fergusson M, Johnson RJ, Schatteman GC, Bothwell M. Nerve growth factor receptor expression in fetal, mature, and diseased human kidneys. Lab Invest 1993; 69: 703-713.
72. Alpers CE, Hudkins KL, Floege J, Johnson RJ. Human renal cortical interstitial cells with some features of smooth muscle cells participate in tubulointerstitial and crescentic glomerular injury. J Am Soc Nephrol 1994; 5: 201-210.
73. Tuveri M, Generini S, Matucci-Cerinic M, Aloe L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet 2000; 356: 1739-1740.
74. Apfel SC, Kessler JA, Adornato BT, Litchy WJ, Sanders C, Rask CA. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology 1998; 51: 695-702.
75. Coassin M, Lambiase A, Micera A, Tirassa P, Aloe L, Bonini S. Nerve growth factor mediates in vitro the expression and release of transforming growth factor-β1 by amniotic membrane. Craefes Arch Clin Exp Ophthalmol 2005; 244: 1-7.
76. Micera A, Puxeddue I, Lambiase A, Antonelli A, Bonini S, Bonini S, et al. The pro-fibrogenic effect of nerve growth factor on conjunctival fibroblasts is mediated by transforming growth factor-β. Clin Exp Allergy 2005; 35: 650-656.
77. Brasile L, Stubenitsky B, Haisch CE, Kon M, Kootstra G. Potential of repairing ischemically damaged kidneys ex vivo. Transplant Proc 2005; 37: 375-376.
78. Kuwae N, Kopple JD, Kalantar-Zadeh K. A low lymphocyte percentage is a predictor of mortality and hospitalization in hemodialysis patients. Clin Nephrol 2005; 63: 22-34.
79. Carracedo J, Ramirez R, Madueno JA, Soriano S, Rodriguez-Benot A, Martin-Malo A, et al. Cell apoptosis and hemodialysis-induced inflammation. Kidney Int 2002; 61 (Suppl 80): S89-S93.
80. Yao Q, Axelsson J, Heimburger O, Stenvinkel P, Lindholm B. Systemic inflammation in dialysis patients with end-stage renal disease: causes and consequences. Minerva Urol Nefrol 2004; 56: 237-248.
81. Gudat F, Laubsher A, Otten U, Pletsher A. Shape changes induced by biologically active peptides and nerve growth factor in blood platelets of rabbits. Br J Pharmacol 1981; 74: 533-538.
82. Bruni A, Bigon E, Boarato E, Mietto L, Leon A, Toffano G. Interaction between nerve growth factor and lysophosphatidylserine on rat peritoneal mast cells. FEBS Lett 1982; 138: 190-192.
83. Matsuda H, Coughlin MD, Bienestock J, Denburg JA. Nerve growth factor promotes human hemopoietic colony growth and differentiation. Proc Natl Acad Sci USA 1988; 85: 6508-6512.
84. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiation of human B lymphocytes. Proc Natl Acad Sci USA 1989; 86: 10059-10063.
85. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992; 79: 2662-2669.
86. Aloe L. Nerve growth factor, human skin ulcers and vascularization. Our experience. Prog Brain Res 2004; 146: 515-522.
87. Lutz M, Krieglestein K, Schmitt S, Dijke P, Sebald W, Wiznemann A, et al. Nerve growth factor mediates activation of the Smad pathway in PC12 cells. Eur J Biochem 2004; 271: 920-931.
88. Maeda A, Horikoshi S, Gohda T, Tsuge T, Maeda K, Tomino Y. Pioglitazone attenuates TGF-β1 induction of fibronectin synthesis and its splicing variant in human mesangial cells via activation of peroxisome proliferator-activated receptor (PPAR)gamma. Cell Biol Int 2005; 29: 422-428.
89. Fuenzalida KM, Aguilera MC, Piderit DG, Ramos PC, Contador D, Quinones V, et al. Peroxisome proliferator-activated receptor gamma is a novel target of the nerve growth factor signaling pathway in PC12 cells. J Biol Chem 2005; 280: 9604-9609.
90. Prozialeck W, Lamar PC, Appel DM. Differential expression of E-cadherin, N-cadherin and β-catenin in proximal and distal segment of the rat nephron. BMC Physiol 2004; 4: 10.
91. Li Y, Yang J, Dai C, Wu C, Liu Y. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 2003; 112: 503-516.
92. Bonofiglio R, Papalia T, Di Piazza D, Antonucci MT, Cassani S, Caroleo MC. Nerve growth factor (NGF) induces TGF-β1 and integrin-linked kinase expression in cultured human tubular cells. Congress of the European Dialysis Transplantation Association, 2005; 205 [Abstract].